These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 15808659
1. Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Bogetti D, Jarzembowski TM, Sankary HN, Manzelli A, Knight PS, Chejfec G, Cotler S, Oberholzer J, Testa G, Benedetti E. Transplant Proc; 2005; 37(1):404-6. PubMed ID: 15808659 [Abstract] [Full Text] [Related]
3. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB. Transplantation; 2003 Sep 15; 76(5):798-802. PubMed ID: 14501856 [Abstract] [Full Text] [Related]
4. The impact of thymoglobulin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplant: a retrospective analysis of 298 consecutive patients. Tchervenkov JI, Tzimas GN, Cantarovich M, Barkun JS, Metrakos P. Transplant Proc; 2004 Sep 15; 36(6):1747-52. PubMed ID: 15350468 [Abstract] [Full Text] [Related]
5. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T. Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109 [Abstract] [Full Text] [Related]
6. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine. Knight RJ, Kerman RH, Podder H, Katz SM, Van Buren CT, Kahan BD. Transplant Proc; 2005 Mar 15; 37(2):1280-2. PubMed ID: 15848695 [Abstract] [Full Text] [Related]
7. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report. Teraoka S, Nomoto K, Kikuchi K, Hirano T, Satomi S, Hasegawa A, Uchida K, Akiyama T, Tanaka S, Babazona T, Shindo K, Nakamura N. Clin Transpl; 2004 Mar 15; ():91-102. PubMed ID: 16704141 [Abstract] [Full Text] [Related]
8. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Monbaliu D, Vekemans K, Hoekstra H, Vaahtera L, Libbrecht L, Derveaux K, Parkkinen J, Liu Q, Heedfeld V, Wylin T, Deckx H, Zeegers M, Balligand E, Buurman W, van Pelt J, Porte RJ, Pirenne J. Ann Surg; 2009 Nov 15; 250(5):808-17. PubMed ID: 19826248 [Abstract] [Full Text] [Related]
11. Adult ABO-incompatible liver transplantation, using A and B donors. Skogsberg U, Breimer ME, Friman S, Mjörnstedt L, Mölne J, Olausson M, Rydberg L, Svalander CT, Bäckman L. Xenotransplantation; 2006 Mar 15; 13(2):154-9. PubMed ID: 16623811 [Abstract] [Full Text] [Related]
12. Outcome of kidney transplantation from nonheart-beating versus heart-beating cadaveric donors. Kokkinos C, Antcliffe D, Nanidis T, Darzi AW, Tekkis P, Papalois V. Transplantation; 2007 May 15; 83(9):1193-9. PubMed ID: 17496535 [Abstract] [Full Text] [Related]
13. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA. Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259 [Abstract] [Full Text] [Related]
14. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE. Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677 [Abstract] [Full Text] [Related]
15. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Bittner HB, Richter M, Kuntze T, Rahmel A, Dahlberg P, Hertz M, Mohr FW. Eur J Cardiothorac Surg; 2006 Feb 27; 29(2):210-5. PubMed ID: 16386921 [Abstract] [Full Text] [Related]
16. UNOS Liver Registry: ten year survivals. Waki K. Clin Transpl; 2006 Feb 27; ():29-39. PubMed ID: 18368704 [Abstract] [Full Text] [Related]
17. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients. Wang D, Wu WZ, Yang SL, Chen JH, Tan JM. Chin Med J (Engl); 2006 Oct 20; 119(20):1683-8. PubMed ID: 17097014 [Abstract] [Full Text] [Related]